Stay updated on Lumateperone Adjunct in Major Depressive Disorder Clinical Trial

Sign up to get notified when there's something new on the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:32:41.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to a multicenter, randomized, double-blind, placebo-controlled study on the efficacy and safety of Lumateperone as adjunctive therapy in the treatment of patients with Major Depressive Disorder.
    Difference
    0.1%
    Check dated 2024-06-06T14:37:09.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying the inclusion and exclusion criteria for participants. Previously, no information was provided in this section.
    Difference
    28%
    Check dated 2024-05-22T21:24:19.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:16:00.000Z thumbnail image

Stay in the know with updates to Lumateperone Adjunct in Major Depressive Disorder Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page.